First Human Clinical Trial Finds CRISPR Gene-edited Cells Safe and Durable for Cancer Therapy
Scientists report positive safety and durability results from the first U.S. test of CRISPR gene editing in human patients with advanced cancer. Technology Networks spoke to the researchers to find out more.
Continue Reading https://www.technologynetworks.com
Join the Discussion